Venlafaxine prescription claims among insured women of reproductive age and pregnant women, 2011-2016.

April D SummersKayla N AndersonElizabeth C AilesScott D GrosseWilliam V BoboNaomi K TepperJennita Reefhuis

Published in: Birth defects research (2021)

Venlafaxine prescription claims were low among women of reproductive age and pregnant women during 2011-2016, with some increasing use over time among women aged 15-19 years.

Keyphrases

pregnant women
pregnancy outcomes
polycystic ovary syndrome
health insurance
cervical cancer screening
metabolic syndrome